Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Apr 2015

Carlino Matteo S, Kwan Vu, Miller David K, Saunders Catherine A B, Yip Desmond, Nagrial Adnan M, Tomlinson Jeanne, Grimmond Sean M, Scolyer Richard A, Kefford Richard F, Biankin Andrew V, Long Georgina V

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Imidazoles
Share to MAP Kinase Kinase Kinases
Share to Molecular Targeted Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oximes

Share to Positron-Emission Tomography

Share to Pyridones

Share to Pyrimidinones

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 24821886
DOI: 10.1200/JCO.2013.51.5783

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma.PMID 24821886Read ↗

Molecular Targeting of a BRAF Mutation in Pancreatic Ductal Adenocarcinoma: Case Report and Literature Review.Semantic proximity Read ↗

KRAS Pathway-based Therapeutic Approaches in Pancreatic Cancer.Semantic proximity Read ↗

BRAF-Driven Pancreatic Cancer: Prevalence, Molecular Features, and Therapeutic Opportunities.Semantic proximity Read ↗

Primary melanoma of the stomach treated by BRAF inhibitor and immunotherapy.Semantic proximity Read ↗

BRAF-MEK inhibition in melanoma brain metastases: a new hope.Semantic proximity Read ↗

A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.Semantic proximity Read ↗

Targeting mutant BRAF and KIT in metastatic melanoma: ASCO 2009 meeting report.Semantic proximity Read ↗

Combined BRAF and MEK inhibition in BRAF-mutant NSCLC.Semantic proximity Read ↗

Remarkable response of BRAFV600E-mutated metastatic pancreatic cancer to BRAF/MEK inhibition: a case reportSemantic proximity Read ↗

Successful BRAF/MEK inhibition in a patient with BRAFV600E-mutated extrapancreatic acinar cell carcinoma.Semantic proximity Read ↗

Antitumor Activity in <i>RAS</i> -Driven Tumors by Blocking AKT and MEKSemantic proximity Read ↗

Primary CNS Metastatic BRAF-mutated Lung Adenocarcinoma With Complete Intracranial Response to BRAF/MEK Inhibition.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.